T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

Updated on: April 01,2024

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

Updated on:April 01,2024

Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainIn cancer patients with neutropenic fever, delaying antibiotic treatment past 60 minutes from the time of fever detection does not reduce

Updated on: January 16,2024

Delaying antibiotics for neutropenic fever may not affect survival of cancer inpatients

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainIn cancer patients with neutropenic fever, delaying antibiotic treatment past 60 minutes from the time of fever detection does not reduce

Updated on:January 16,2024

Researchers improve classification of pancreatic cancer to better predict patient outcomes

by Katie Sullivan,University of TorontoSangeetha Kalimuthu, an assistant professor of laboratory medicine and pathobiology at U of T and a gastrointestinal pathologist at UHN, is the co-author o

Updated on: June 15,2024

Researchers improve classification of pancreatic cancer to better predict patient outcomes

by Katie Sullivan,University of TorontoSangeetha Kalimuthu, an assistant professor of laboratory medicine and pathobiology at U of T and a gastrointestinal pathologist at UHN, is the co-author o

Updated on:June 15,2024

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on: January 29,2024

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on:January 29,2024

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on: January 22,2024

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on:January 22,2024

Direct-to-consumer cancer testing could be beneficial, expert says, but it's not a substitute

by Leha Byrd,Virginia Commonwealth UniversityWhile the availability of direct-to-consumer genetic testing could be helpful, it also should not dissuade people from seeking professional advice re

Updated on: April 01,2024

Direct-to-consumer cancer testing could be beneficial, expert says, but it's not a substitute

by Leha Byrd,Virginia Commonwealth UniversityWhile the availability of direct-to-consumer genetic testing could be helpful, it also should not dissuade people from seeking professional advice re

Updated on:April 01,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on: January 22,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on:January 22,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on: February 01,2024

Taming overactive molecular signaling in renal cell cancer

by Johns Hopkins University School of MedicineMurine renal tumors with Tsc2 loss have increased TFEB/TFE3 nuclear localization. Credit: Clarence Rachel Villanueva and Adrianna A. Mendes,Nat

Updated on:February 01,2024

Researchers explore why patients don't follow up with their doctors after receiving a positive colorectal cancer test

by American Academy of Family PhysiciansReasons for no colonoscopy after an unfavorable screening result in Dutch colorectal cancer screening: a nation-wise questionnaire. Credit:The Annals

Updated on: February 01,2024

Researchers explore why patients don't follow up with their doctors after receiving a positive colorectal cancer test

by American Academy of Family PhysiciansReasons for no colonoscopy after an unfavorable screening result in Dutch colorectal cancer screening: a nation-wise questionnaire. Credit:The Annals

Updated on:February 01,2024

Supporting smokers with new lung health checks could save thousands of lives

by University of NottinghamCredit: Unsplash/CC0 Public DomainResearchers and national cancer charities strongly welcome the UK Government's decision to back National Screening Committee recom

Updated on: January 30,2024

Supporting smokers with new lung health checks could save thousands of lives

by University of NottinghamCredit: Unsplash/CC0 Public DomainResearchers and national cancer charities strongly welcome the UK Government's decision to back National Screening Committee recom

Updated on:January 30,2024

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared

Updated on: April 20,2024

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared

Updated on:April 20,2024